UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Abstract 909: Defining molecular and laboratory predictive biomarkers of response to cisplatin-based neoadjuvant chemotherapy (NC) in muscle-invasive bladder cancer (MIBC) - preliminary results and future plans

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.909-909

2014

Volltextzugriff (PDF)

Baseline neutrophil to lymphocyte ratio as a prognostic marker for patients with muscle-invasive bladder cancer being treated with neoadjuvant chemotherapy

Journal of clinical oncology, 2016-01, Vol.34 (2_suppl), p.468-468

2016

Volltextzugriff (PDF)

Evaluation of the neutrophil-lymphocyte ratio (NLR) during neoadjuvant chemotherapy (NC) for muscle-invasive bladder cancer (MIBC) and correlation with pathologic response to treatment

Journal of clinical oncology, 2014-02, Vol.32 (4_suppl), p.351-351

2014

Volltextzugriff (PDF)

Do special access programs facilitate off-label prescribing? The experience of enzalutamide in prostate cancer

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.6550-6550

2014

Volltextzugriff (PDF)

Clinical activity of enzalutamide against metastatic castration-resistant prostate cancer (mCRPC) in patients who have progressed on abiraterone acetate: The Princess Margaret experience

Journal of clinical oncology, 2014-02, Vol.32 (4_suppl), p.159-159

2014

Volltextzugriff (PDF)

Neoadjuvant gemcitabine-cisplatin (GC) for muscle-invasive bladder cancer (MIBC): Does midway CT staging predict for pathologic complete response (pCR)?

Journal of clinical oncology, 2014-02, Vol.32 (4_suppl), p.306-306

2014

Volltextzugriff (PDF)

MP58-04 DENSE DOSE MVAC VERSUS GC IN PATIENTS WITH CT3-4A BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY: A REAL WORLD EXPERIENCE

The Journal of urology, 2017-04, Vol.197 (4), p.e773-e774

2017

Volltextzugriff (PDF)

Retreatment of men with metastatic castrate-resistant prostate cancer with abiraterone: Retreatment of Men With Mcrpc With Abiraterone

The Prostate, 2014-10, Vol.74 (14), p.1462-1464

2014

Volltextzugriff (PDF)

Low-dose abiraterone (abi) with food in men with metastatic castration-resistant prostate cancer (mCRPC): The Princess Margaret Cancer Centre experience

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.5077-5077

2014

Volltextzugriff (PDF)

A single-arm, phase II, multicenter trial of sunitinib (SU) in locally advanced or metastatic pheochromocytoma/paraganglioma (PC/PG): Updated interim results

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e15621-e15621

2014

Volltextzugriff (PDF)

A single-arm, phase II, multicenter trial of sunitinib maleate (SU) in locally advanced or metastatic pheochromocytoma/paraganglioma (PC/PG): Interim results

Journal of clinical oncology, 2014-02, Vol.32 (4_suppl), p.431-431

2014

Volltextzugriff (PDF)

Dose-modified abiraterone acetate (AA) in men with metastatic castration-resistant prostate cancer (mCRPC): The Princess Margaret Cancer Centre (PM) experience

Journal of clinical oncology, 2014-02, Vol.32 (4_suppl), p.61-61

2014

Volltextzugriff (PDF)

MP72-15 THE INTERVAL BETWEEN DIAGNOSIS AND RADICAL CYSTECTOMY DOES NOT IMPACT THE OUTCOMES OF PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY

The Journal of urology, 2015-04, Vol.193 (4), p.e926-e927

2015

Volltextzugriff (PDF)

PD41-05 FINAL PATHOLOGIC STAGE AFTER NEOADJUVANT CHEMOTHERAPY AND RADICAL CYSTECTOMY FOR BLADDER CANCER: DOES PT0 PREDICT BETTER SURVIVAL THAN PTA/PTIS/PT1?

The Journal of urology, 2015-04, Vol.193 (4), p.e841-e842

2015

Volltextzugriff (PDF)

MP65-06 A MULTI-INSTITUTIONAL ANALYSIS OF OUTCOMES IN PATIENTS WITH CLINICALLY NODE POSITIVE UROTHELIAL BLADDER CANCER TREATED WITH INDUCTION CHEMOTHERAPY AND RADICAL CYSTECTOMY

The Journal of urology, 2015-04, Vol.193 (4), p.e809-e809

2015

Volltextzugriff (PDF)

Elective intensive care unit admissions for organ donation in patients with terminal brain glioma: Case report

SAGE open medical case reports, 2024, Vol.12, p.2050313X241235009-2050313X241235009

2024

Volltextzugriff (PDF)

The Impact of Special Access Programs (SAP) on Prescribing Patterns in Metastatic Castration Resistant Prostate Cancer (mCRPC)

International Journal of Clinical Oncology and Cancer Research, 2021, Vol.6 (1), p.33

2021

Volltextzugriff (PDF)

Inflammatory breast cancer and secondary Pure Red Cell Aplasia

Acta oncologica (Stockholm, Sweden), 2011, Vol.50 (5), p.727-728

2011

Volltextzugriff (PDF)

Antigen Distributions of Rotavirus and Adenovirus Detected by Enzyme Immuno Assay (EIA) from Acute Gastroenteritis Patients in Seoul

Journal of bacteriology and virology, 2014, Vol.44 (1), p.108

2014

Volltextzugriff (PDF)

Epidemiological Characterization of Respiratory Viruses Detected from Acute Respiratory Patients in Seoul

Annals of clinical microbiology, 2013, Vol.16 (4), p.188

2013

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(18)
Berichte
(2)

Sprache

Englisch
(18)
Koreanisch
(2)

Erscheinungsjahr

n.n

Thema

1 weiteren anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Abstract 909: Defining molecular and laboratory predictive biomarkers of response to cisplatin-based neoadjuvant chemotherapy (NC) in muscle-invasive bladder cancer (MIBC) - preliminary results and future plans

Baseline neutrophil to lymphocyte ratio as a prognostic marker for patients with muscle-invasive bladder cancer being treated with neoadjuvant chemotherapy

Evaluation of the neutrophil-lymphocyte ratio (NLR) during neoadjuvant chemotherapy (NC) for muscle-invasive bladder cancer (MIBC) and correlation with pathologic response to treatment

Do special access programs facilitate off-label prescribing? The experience of enzalutamide in prostate cancer

Clinical activity of enzalutamide against metastatic castration-resistant prostate cancer (mCRPC) in patients who have progressed on abiraterone acetate: The Princess Margaret experience

Neoadjuvant gemcitabine-cisplatin (GC) for muscle-invasive bladder cancer (MIBC): Does midway CT staging predict for pathologic complete response (pCR)?

MP58-04 DENSE DOSE MVAC VERSUS GC IN PATIENTS WITH CT3-4A BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY: A REAL WORLD EXPERIENCE

Retreatment of men with metastatic castrate-resistant prostate cancer with abiraterone: Retreatment of Men With Mcrpc With Abiraterone

Low-dose abiraterone (abi) with food in men with metastatic castration-resistant prostate cancer (mCRPC): The Princess Margaret Cancer Centre experience

A single-arm, phase II, multicenter trial of sunitinib (SU) in locally advanced or metastatic pheochromocytoma/paraganglioma (PC/PG): Updated interim results

A single-arm, phase II, multicenter trial of sunitinib maleate (SU) in locally advanced or metastatic pheochromocytoma/paraganglioma (PC/PG): Interim results

Dose-modified abiraterone acetate (AA) in men with metastatic castration-resistant prostate cancer (mCRPC): The Princess Margaret Cancer Centre (PM) experience

MP72-15 THE INTERVAL BETWEEN DIAGNOSIS AND RADICAL CYSTECTOMY DOES NOT IMPACT THE OUTCOMES OF PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY

PD41-05 FINAL PATHOLOGIC STAGE AFTER NEOADJUVANT CHEMOTHERAPY AND RADICAL CYSTECTOMY FOR BLADDER CANCER: DOES PT0 PREDICT BETTER SURVIVAL THAN PTA/PTIS/PT1?

MP65-06 A MULTI-INSTITUTIONAL ANALYSIS OF OUTCOMES IN PATIENTS WITH CLINICALLY NODE POSITIVE UROTHELIAL BLADDER CANCER TREATED WITH INDUCTION CHEMOTHERAPY AND RADICAL CYSTECTOMY

Elective intensive care unit admissions for organ donation in patients with terminal brain glioma: Case report

The Impact of Special Access Programs (SAP) on Prescribing Patterns in Metastatic Castration Resistant Prostate Cancer (mCRPC)

Inflammatory breast cancer and secondary Pure Red Cell Aplasia

Antigen Distributions of Rotavirus and Adenovirus Detected by Enzyme Immuno Assay (EIA) from Acute Gastroenteritis Patients in Seoul

Epidemiological Characterization of Respiratory Viruses Detected from Acute Respiratory Patients in Seoul

Aktive Filter

Suchergebnisse filtern